Metabolomics profiling for diagnosis of acute renal failure after cardiopulmonary bypass
Rapid Communications in Mass Spectrometry · 15.05.2024 · 38 (9)
DOI: 10.1002/rcm.9728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 14.03.2024. Verfasst von Sevilay Erdoğan Kablan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Cardiopulmonary Bypass, Acute Kidney Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Hacettepe University Scientific Research Coordination Unit, Hacettepe Üniversitesi.
Abstract (Originalsprache)
Rationale
Acute renal failure (ARF) is one of the most serious complications of cardiopulmonary bypass (CPB) surgery. Serum creatinine level is a key compound examined to understand whether renal function is normal. However, its level may vary based on age, gender, race, muscle mass, nutrition, and drugs taken by an individual. In addition, it may not be detected without a 50% reduction in renal function and may lead to delays in treatment. New markers are needed for early diagnosis of ARF. They were determined for early diagnosis of ARF after CPB. Metabolic differences in plasma samples of individuals who developed and did not develop ARF after cardiopulmonary bypass were determined.
Methods
This study was the first to perform an untargeted metabolomics analysis for early diagnosis of ARF after CPB surgery. Plasma samples were taken from 105 patients (9 ARF patients) at five time points to identify the time at which a more accurate ARF diagnosis can be made. A total of 687 samples, including quality control samples, were analyzed.
Results
Two hundred twenty‐six metabolites were identified using retention index libraries. Based on the statistical evaluations, tryptophan, threonine, and methionine were found in lower concentrations in patients with ARF compared to the control group at all time points. Whereas gluconic acid, hypoxanthine, and lactic acid showed a decreasing trend over time, longitudinal analysis showed that cysteine, hippuric acid, and uric acid levels increased over time in the ARF group.
Conclusions
These metabolites are candidate biomarkers for early diagnosis of ARF as well as biomarkers for tracking the recovery of ARF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
- Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.
- Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
- Koç University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Sevilay Erdoğan Kablan
Förderung
- Hacettepe University Scientific Research Coordination Unit
- Hacettepe Üniversitesi
Zitieren
APA
Erdoğan Kablan, S., Yılmaz, A., Syed, H., Kocabeyoğlu, S. S., Kervan, Ü., Özaltın, N., & Nemutlu, E. (2024). Metabolomics profiling for diagnosis of acute renal failure after cardiopulmonary bypass. Rapid Communications in Mass Spectrometry, 38(9). https://doi.org/10.1002/rcm.9728
Vancouver
Erdoğan Kablan S, Yılmaz A, Syed H, Kocabeyoğlu SS, Kervan Ü, Özaltın N, et al. Metabolomics profiling for diagnosis of acute renal failure after cardiopulmonary bypass. Rapid Communications in Mass Spectrometry. 2024;38(9). doi:10.1002/rcm.9728
BibTeX
@article{ErdoanKablan2024,
author = {Erdoğan Kablan, Sevilay and Yılmaz, Abdulkadir and Syed, Hamzah and Kocabeyoğlu, Sinan Sabit and Kervan, Ümit and Özaltın, Nuran and Nemutlu, Emirhan},
title = {Metabolomics profiling for diagnosis of acute renal failure after cardiopulmonary bypass},
journal = {Rapid Communications in Mass Spectrometry},
year = {2024},
volume = {38},
number = {9},
doi = {10.1002/rcm.9728}
}
EUVIMED